Sarah Bridge

829 total citations
8 papers, 378 citations indexed

About

Sarah Bridge is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Sarah Bridge has authored 8 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Epidemiology and 2 papers in Surgery. Recurrent topics in Sarah Bridge's work include Antifungal resistance and susceptibility (3 papers), Fungal Infections and Studies (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). Sarah Bridge is often cited by papers focused on Antifungal resistance and susceptibility (3 papers), Fungal Infections and Studies (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). Sarah Bridge collaborates with scholars based in United Kingdom, United States and Australia. Sarah Bridge's co-authors include Philip M. Beart, MacDonald J. Christie, Lewis B. James, I. Schweitzer, K P Maguire, J. W. G. Tiller, Joshua Rhein, Conrad Muzoora, David B. Meya and David R. Boulware and has published in prestigious journals such as PLoS ONE, Biological Psychiatry and Brain Research.

In The Last Decade

Sarah Bridge

8 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Bridge United Kingdom 8 191 99 82 74 68 8 378
Kathy L. Kopnisky United States 9 71 0.4× 91 0.9× 26 0.3× 18 0.2× 47 0.7× 11 380
Worthy Warnack United States 8 150 0.8× 98 1.0× 19 0.2× 41 0.6× 17 0.3× 15 325
Ulla Hasselrot United States 10 180 0.9× 214 2.2× 40 0.5× 20 0.3× 36 0.5× 14 494
Arash Hellysaz Sweden 9 59 0.3× 62 0.6× 35 0.4× 11 0.1× 27 0.4× 14 256
Magdalena Mazur Sweden 9 69 0.4× 147 1.5× 52 0.6× 53 0.7× 49 0.7× 12 485
Daniel Peterlik Germany 11 173 0.9× 131 1.3× 60 0.7× 12 0.2× 9 0.1× 27 417
Laura E. Peters United States 7 114 0.6× 35 0.4× 20 0.2× 18 0.2× 13 0.2× 10 341
Fernanda G. Q. Barros‐Aragão Brazil 12 76 0.4× 101 1.0× 15 0.2× 28 0.4× 28 0.4× 17 379
Venusia Covelli Italy 11 72 0.4× 60 0.6× 18 0.2× 21 0.3× 13 0.2× 41 349
Fabio Panariello Italy 9 91 0.5× 78 0.8× 20 0.2× 18 0.2× 15 0.2× 21 282

Countries citing papers authored by Sarah Bridge

Since Specialization
Citations

This map shows the geographic impact of Sarah Bridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Bridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Bridge more than expected).

Fields of papers citing papers by Sarah Bridge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Bridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Bridge. The network helps show where Sarah Bridge may publish in the future.

Co-authorship network of co-authors of Sarah Bridge

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Bridge. A scholar is included among the top collaborators of Sarah Bridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Bridge. Sarah Bridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Bridge, Sarah, Kathy Huppler Hullsiek, Emily E Evans, et al.. (2021). Evaluation of the BioFire® FilmArray® Meningitis/Encephalitis panel in an adult and pediatric Ugandan population. Journal de Mycologie Médicale. 31(3). 101170–101170. 23 indexed citations
2.
Ellis, Jayne, Ananta Bangdiwala, Fiona V Cresswell, et al.. (2019). The Changing Epidemiology of HIV-Associated Adult Meningitis, Uganda 2015–2017. Open Forum Infectious Diseases. 6(10). ofz419–ofz419. 38 indexed citations
3.
Mpoza, Edward, Liliane Mukaremera, Andrew Akampurira, et al.. (2018). Evaluation of a point-of-care immunoassay test kit ‘StrongStep’ for cryptococcal antigen detection. PLoS ONE. 13(1). e0190652–e0190652. 22 indexed citations
4.
Jäkel, Anne, et al.. (2012). A Systematic Review of Economic Evaluations in Second and Later Lines of Therapy for the Treatment of Non-Small Cell Lung Cancer. Applied Health Economics and Health Policy. 11(1). 27–43. 16 indexed citations
5.
Kell, Philip, et al.. (2007). Factors that predict changing the type of phosphodiesterase type 5 inhibitor medication among men in the UK. British Journal of Urology. 99(4). 860–863. 14 indexed citations
6.
Maguire, K P, et al.. (1987). The dexamethasone suppression test: Importance of dexamethasone concentrations. Biological Psychiatry. 22(8). 957–967. 46 indexed citations
7.
Bridge, Sarah, MacDonald J. Christie, & Philip M. Beart. (1986). No change in neostriatal D-2 dopamine receptors after NMDA lesions of rat prefrontal cortex. Pharmacology Biochemistry and Behavior. 24(6). 1829–1832. 19 indexed citations
8.
Christie, MacDonald J., Sarah Bridge, Lewis B. James, & Philip M. Beart. (1985). Excitotoxin lesions suggest an aspartatergic projection from rat medial prefrontal cortex to ventral tegmental area. Brain Research. 333(1). 169–172. 200 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026